Interleukin Secretion
| Epic code: | SPL6 |
| Downtime form: | A-1a Doctor/Provider Orders - Pathology Core and Specialty Care Nursery |
VA Diagnostic Immunology Lab
Veterans Affairs Hospital Rm. 223, Bldg. 41
319-338-0581, EXT 7550 dial 158 from UIHC
Veterans Affairs Hospital Rm. 223, Bldg. 41
319-338-0581, EXT 7550 dial 158 from UIHC
Specimen(s):
Whole Blood
Specimen
Instructions:
Call VA Diagnostic Immunology Lab as soon as sample is drawn
(319-338-0581) ext. 7550.
Blood cannot be held longer than 24 hours before processing.
ATTENTION: For samples drawn in Medicine Specialty Clinics and Pediatric Specialty Clinics place in VA DIAG. IMM (Ballas) box.
For samples drawn on the floor please call the lab for pick up
(319-338-0581) ext. 7550.
(319-338-0581) ext. 7550.
Blood cannot be held longer than 24 hours before processing.
ATTENTION: For samples drawn in Medicine Specialty Clinics and Pediatric Specialty Clinics place in VA DIAG. IMM (Ballas) box.
For samples drawn on the floor please call the lab for pick up
(319-338-0581) ext. 7550.
Minimum:
20 mL; sodium heparin green tops. Do not use a needle smaller than 21
gauge.
Delivery Instructions:
Keep at room temperature. Do not
refrigerate. Do not centrifuge.
Reference Range:
Internal control and normal range reported with each sample.
Comments:
This assay is run Monday through Thursday during working hours and
Friday 8 a.m. to noon. This assay is run using viable
lymphocytes.
This assay examines the ability of a patient's lymphocytes to generate IL2, and other cytokines, in response to a physiologic (via the T cell receptor complex) as well as a pharmacological stimulus. An abnormal response would suggest a T lymphocyte immune deficiency and would be consistent with a clinical picture of recurrent infection, failure to thrive and, possibly, recurrent tumors.
This assay examines the ability of a patient's lymphocytes to generate IL2, and other cytokines, in response to a physiologic (via the T cell receptor complex) as well as a pharmacological stimulus. An abnormal response would suggest a T lymphocyte immune deficiency and would be consistent with a clinical picture of recurrent infection, failure to thrive and, possibly, recurrent tumors.